Kestra Advisory Services’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $648K | Buy |
7,104
+310
| +5% | +$28.3K | ﹤0.01% | 1787 |
|
|
2025
Q1 | $769K | Sell |
6,794
-515
| -7% | -$58.3K | ﹤0.01% | 1550 |
|
|
2024
Q4 | $772K | Sell |
7,309
-981
| -12% | -$104K | ﹤0.01% | 1560 |
|
|
2024
Q3 | $895K | Sell |
8,290
-194
| -2% | -$20.9K | ﹤0.01% | 1389 |
|
|
2024
Q2 | $921K | Buy |
8,484
+2,165
| +34% | +$235K | 0.01% | 1371 |
|
|
2024
Q1 | $834K | Buy |
6,319
+274
| +5% | +$36.2K | 0.01% | 1355 |
|
|
2023
Q4 | $736K | Sell |
6,045
-143
| -2% | -$17.4K | 0.01% | 1283 |
|
|
2023
Q3 | $694K | Buy |
6,188
+820
| +15% | +$92K | 0.01% | 1185 |
|
|
2023
Q2 | $782K | Buy |
5,368
+43
| +0.8% | +$6.26K | 0.01% | 1094 |
|
|
2023
Q1 | $688K | Sell |
5,325
-5,385
| -50% | -$696K | 0.01% | 1124 |
|
|
2022
Q4 | $1.37M | Buy |
10,710
+2,407
| +29% | +$307K | 0.01% | 910 |
|
|
2022
Q3 | $868K | Sell |
8,303
-2,577
| -24% | -$269K | 0.01% | 1039 |
|
|
2022
Q2 | $1.14M | Buy |
10,880
+1,956
| +22% | +$205K | 0.01% | 912 |
|
|
2022
Q1 | $1.14M | Buy |
8,924
+1,357
| +18% | +$174K | 0.01% | 897 |
|
|
2021
Q4 | $933K | Sell |
7,567
-977
| -11% | -$120K | 0.01% | 1020 |
|
|
2021
Q3 | $1.21M | Buy |
8,544
+878
| +11% | +$125K | 0.01% | 908 |
|
|
2021
Q2 | $1.2M | Buy |
7,666
+151
| +2% | +$23.6K | 0.01% | 853 |
|
|
2021
Q1 | $1.17M | Buy |
7,515
+1,997
| +36% | +$310K | 0.01% | 805 |
|
|
2020
Q4 | $816K | Buy |
5,518
+5,466
| +10,512% | +$808K | 0.01% | 959 |
|
|
2020
Q3 | $449K | Buy |
+52
| New | +$449K | 0.01% | 938 |
|